RxDoctor Payments DataLook up a doctor →

April Swoner, NP

Family · Hermitage, TNNPI 1972007201

Payments from drug & device makers

$246,466in general payments, 2019–2025

Across 2,133 payments — averaging $115.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$52K
  • Acadia Pharmaceuticals Inc$38K
  • Biohaven Pharmaceuticals, Inc.$33K
  • Biohaven Pharmaceutical Holding Company Ltd.$26K
  • ANI Pharmaceuticals, Inc.$25K
  • Amgen$16K
  • plus $56K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)324$51,619
Acadia Pharmaceuticals Inc92$38,192
Biohaven Pharmaceuticals, Inc.58$33,090
Biohaven Pharmaceutical Holding Company Ltd.54$25,963
ANI Pharmaceuticals, Inc.100$25,297
Amgen62$15,803
Axsome Therapeutics, Inc.27$11,968
Pfizer54$9,546
MDD US Operations, LLC83$6,457
UCB, Inc.97$3,278
EMD Serono, Inc.91$2,563
Biogen114$2,152
Neurocrine Biosciences, Inc.53$1,941
SK Life Science, Inc.72$1,639
Novartis87$1,624
AstraZeneca(2 entities)56$1,458
Teva Pharmaceuticals USA, Inc.98$1,410
TG Therapeutics, Inc.35$1,035
Lundbeck LLC38$892
Sanofi27$752
Upsher-smith Laboratories LLC37$649
Impel Pharmaceuticals Inc.27$564
Johnson & Johnson37$532
Argenx US, Inc.20$508
Eisai Inc.21$492
Lilly USA, LLC25$490
Otsuka America Pharmaceutical, Inc.25$487
Supernus Pharmaceuticals, Inc.28$472
Bristol Myers Squibb31$458
Genentech USA, Inc.20$449
CSL Behring19$422
Sumitomo Pharma America, Inc.26$378
Sunovion Pharmaceuticals Inc.19$330
Neurelis, Inc.17$328
Avanir Pharmaceuticals, Inc.12$295
Cycle Pharmaceuticals Inc12$278
Catalyst Pharmaceuticals, Inc.14$266
Amneal Pharmaceuticals LLC16$250
Scilex Pharmaceuticals Inc.10$202
Azurity Pharmaceuticals, Inc.9$177
Banner Life Sciences, LLC10$169
Harmony Biosciences LLC7$152
Kyowa Kirin, Inc.7$140
E.r. Squibb & Sons, L.L.C.2$122
Tanabe Pharma America, Inc.7$120
Boston Scientific3$112
Adamas Pharmaceuticals, Inc.5$108
Mallinckrodt Hospital Products Inc.4$92
Alnylam Pharmaceuticals Inc.5$90
Grifols USA, LLC4$87
Avion Pharmaceuticals5$86
Vanda Pharmaceuticals Inc.5$79
Acorda Therapeutics, Inc4$67
Akcea Therapeutics, Inc.3$66
Octapharma USA, Inc.3$52
Xeris Pharmaceuticals, Inc.2$39
Almatica Pharma LLC2$29
Amylyx Pharmaceuticals, Inc.1$26
Impel Pharmaceuticals LLC1$24
Averitas Pharma Inc.1$24

How this compares

$246,466 in reported general payments places this provider in the 95th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee →

Medicare billing

Part B allowed, 2024
$27,330
Medicare patients
190
Services billed
263

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Hermitage

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →